Skip to main content
Knowledge-Pathway-Hero-image

Reducing Batch Size to Improve Slide Turnaround Time

David Newell
David Newell MBA, HT(ASCP)CM

The Leica Biosystems Process and Solutions Optimization team has partnered with Queen Elizabeth Hospital to examine how to optimize their processes to reduce turn-around-time. QEH is most interested in having slides assigned to their Pathologists earlier in the day. The Process and Solutions Optimization team identified a few changes to help recognize and monitor their goals.

Following a workflow assessment, it was determined that the large batch sizes in use were causing delays and creating large wait times in several steps of the Histology processes. It was recommended that the laboratory reduce the batch sizes from embedding to case assembly in order to decrease the wait times and result in slides being completed earlier.

Figure 1 shows the comparison between large batches and small batches. Using a large batch takes more time to complete, whereas the smaller batch allows work to move to the next step in the process more quickly.

Figure 1.

Image
reducing-batch-size-figure1

Figure 2 shows the average daily number of slides ready for QC by 7AM (embedding starts daily at 5AM). The Assessment data was collected during the on-site assessment in March 2018. The Pre-Batching data was collected by QEH staff in April 2018. The Post-Batching data was collected by QEH staff after the switch to smaller batch sizes in May 2018. That resulted in a 177% improvement in slides ready for QC compared to the assessment.

Figure 2.

Image
reducing-batch-size-figure2

During the initial assessment in March 2018, the Pathologists had complained that on most days they did not receive any slides until after 10AM. In the initial month after the switch in batch sizes, slides were ready for the Pathologist on average by 8:09AM.

Projections and Realized Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.


발표자 소개

David Newell
David Newell , MBA, HT(ASCP)CM

David Newell has been working in the field of Laboratory Medicine for over 20 years. He has experience working on the Laboratory Informatics Implementation team, leading installations across North America. Before joining Leica Biosystems, he served in several roles at a large reference laboratory in Arizona, including over eight years as a Histotechnologist. He has experience managing an Anatomic Pathology Department for a level 1 trauma center and a dermatology laboratory. David holds a Bachelor of Science in Kinesiology and Master of Business Administration and Histologic Technician (HT) certification through the American Society for Clinical Pathology (ASCP). He received his Six Sigma and Lean training through Quest Diagnostics in 2002 and 2010, respectively.

라이카 바이오시스템즈 Knowledge Pathway 콘텐츠는 에서 이용할 수 있는 라이카 바이오시스템즈 웹사이트 이용 약관의 적용을 받습니다. 법적고지. 라이카 바이오시스템즈 웨비나, 교육 프레젠테이션 및 관련 자료는 특별 주제 관련 일반 정보를 제공하지만 의료, 규정 또는 법률 상담으로 제공되지 않으며 해석되어서는 안 됩니다. 관점과 의견은 발표자/저자의 개인 관점과 의견이며 라이카 바이오시스템즈, 그 직원 또는 대행사의 관점이나 의견을 나타내거나 반영하지 않습니다. 제3자 자원 또는 콘텐츠에 대한 액세스를 제공하는 콘텐츠에 포함된 모든 링크는 오직 편의를 위해 제공됩니다.

모든 제품 사용에 다양한 제품 및 장치의 제품 정보 가이드, 부속 문서 및 작동 설명서를 참조해야 합니다.

Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.